Aaron C Siegmund from 230 N Wake Forest Ave, Ventura, CA 93003, age 58, Phone: 8055067434

Resumes

Appraiser Trainee

view source

Location:

Loveland, CO

Industry:

Hospitality

Work:

Real Estate
Appraiser Trainee
The Crawford Hotel Sep 2016 - Apr 2017
Front Desk Agent
Colorado Wholesale Feb 2015 - Aug 2016
Commissioned Outside Salesman
Xanterra Parks & Resorts Apr 2014 - Sep 2014
Seasonal Dining Room Manager
Enterprise Rent-A-Car Jun 2013 - Aug 2013
Management Trainee Intern

Education:

Colorado State University 2010 - 2014
Bachelors, Bachelor of Science, Hospitality, Hospitality Management Smoky Hill High School 2006 - 2010

Skills:

Sales
Team Building
Hospitality
Hotels
Customer Service
Event Management
Microsoft Office
Social Media
Microsoft Word
Microsoft Excel
Public Speaking
Fundraising
Inventory Management
Public Relations
Marketing

Certifications:

National Restaurant Association
Prostart

Senior Scientist

view source

Location:

230 north Wake Forest Ave, Ventura, CA 93003

Industry:

Biotechnology

Work:

Amgen since Jun 1999
Senior Scientist
Amgen Inc., USA since 1999
Scientist
Chiron Corporation 1994 - 1999
Scientist
Berlex Biosciences 1989 - 1994
Research Associate

Education:

California Lutheran University 2008 - 2012
MBA student University of Redlands 1985 - 1989

Skills:

Research

Languages:

English

Us Patents

Substituted Heterocyclic Compounds And Methods Of Use
view source
US Patent:

7049318, May 23, 2006
Filed:

Jul 23, 2004
Appl. No.:

10/897884
Inventors:

Celia Dominguez - Thousand Oaks CA, US
Timothy Scot Harvey - Thousand Oaks CA, US
Longbin Liu - Thousand Oaks CA, US
Aaron Siegmund - Oxnard CA, US
Assignee:

AMGEN Inc. - Thousand Oaks CA
International Classification:

A61K 31/505
US Classification:

514269, 544242
Abstract:

The present invention relates to compounds having the general formula.

Substituted Heterocyclic Compounds And Methods Of Use
view source
US Patent:

7429594, Sep 30, 2008
Filed:

Aug 20, 2004
Appl. No.:

10/923067
Inventors:

Longbin Liu - Thousand Oaks CA, US
Patricia Lopez - West Hills CA, US
Manoj Bajpai - Simi Valley CA, US
Aaron C. Siegmund - Ventura CA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C07D 401/04
A61K 31/519
US Classification:

5142591, 514272, 544279, 544321
Abstract:

The present invention relates to compounds having the general formula.

Substituted Heterocyclic Compounds And Methods Of Use
view source
US Patent:

7504403, Mar 17, 2009
Filed:

Jan 21, 2005
Appl. No.:

11/041151
Inventors:

Michael J. Frohn - Thousand Oaks CA, US
Longbin Liu - Thousand Oaks CA, US
Patricia Lopez - West Hills CA, US
Aaron Siegmund - Ventura CA, US
Seifu Tadesse - Simi Valley CA, US
Nuria Tamayo - Newbury Park CA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C07D 487/04
A61K 31/506
US Classification:

5142591, 5142594, 51425941, 5142595, 544279, 544281, 544282
Abstract:

The present invention relates to pyrimidinones and pyridones and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.

Substituted Heterocycles And Methods Of Use
view source
US Patent:

7652009, Jan 26, 2010
Filed:

Nov 29, 2005
Appl. No.:

11/289659
Inventors:

Steven Bellon - Wellesley MA, US
Shon Booker - Thousand Oaks CA, US
Noel D'Angelo - Thousand Oaks CA, US
Celia Dominguez - Los Angeles CA, US
Ingrid Fellows - Fresno CA, US
Matthew Lee - Calabasas CA, US
Longbin Liu - Thousand Oaks CA, US
Elizabeth Rainbeau - Port Hueneme CA, US
Aaron C. Siegmund - Ventura CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Yuan Cheng - Newbury Park CA, US
Assignee:

Amgem Inc. - Thousand Oaks CA
International Classification:

A61K 31/506
C07D 401/02
C07D 239/22
US Classification:

51425204, 514269, 544238, 544242, 544298, 544319
Abstract:

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Substituted Amide Derivatives And Methods Of Use
view source
US Patent:

8088794, Jan 3, 2012
Filed:

Nov 12, 2010
Appl. No.:

12/945575
Inventors:

David Bauer - Sudbury MA, US
Steven Bellon - Wellesley MA, US
Alessandro Boezio - Somerville MA, US
Shon Booker - Thousand Oaks CA, US
Deborah Choquette - Medford MA, US
Derin C. D'Amico - Newbury Park CA, US
Noel D'Angelo - Thousand Oaks CA, US
Celia Dominguez - Los Angeles CA, US
Ingrid M. Fellows - Fresno CA, US
Julie Germain - Medford, CA
Russell Graceffa - Hampton NH, US
Jean-Christophe Harmange - Andover MA, US
Satoko Hirai - Cambridge MA, US
Daniel La - Brookline MA, US
Matthew Lee - Calabasas CA, US
Longbin Liu - Thousand Oaks CA, US
Mark H. Norman - Thousand Oaks CA, US
Michele Potashman - Cambridge MA, US
Philip Roveto - San Francisco CA, US
Aaron C. Siegmund - Ventura CA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Assignee:

Amgen Inc. - Thousands Oaks CA
International Classification:

A61K 31/47
C07D 453/02
US Classification:

514312, 546135
Abstract:

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Nitrogen-Containing Heterocyclyl Ketones And Methods Of Use
view source
US Patent:

8314087, Nov 20, 2012
Filed:

Feb 15, 2008
Appl. No.:

12/070309
Inventors:

Brian K. Albrecht - Cambridge MA, US
Steven Bellon - Wellesley MA, US
Shon Booker - Thousand Oaks CA, US
Alan C. Cheng - Cambridge MA, US
Derin D'Amico - Newbury Park CA, US
Noel D'Angelo - Thousand Oaks CA, US
Jean-Christophe Harmange - Andover MA, US
Longbin Liu - Thousand Oaks CA, US
Mark H. Norman - Thousand Oaks CA, US
Aaron C. Siegmund - Ventura CA, US
Markian Stec - Moorpark CA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Assignee:

Amgen Inc. - South San Francisco CA
International Classification:

C07D 215/233
C07D 413/14
C07D 205/08
C07D 409/14
C07D 401/14
C07D 239/36
A61K 31/4709
A61K 31/5355
A61K 31/397
A61K 31/497
A61K 31/506
A61P 35/00
US Classification:

51421002, 514312, 5142352, 51425204, 51425505, 514274, 540200, 544128, 544238, 544405, 544318, 546153
Abstract:

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Inhibitors Of Pi3 Kinase
view source
US Patent:

8415376, Apr 9, 2013
Filed:

May 29, 2009
Appl. No.:

12/995431
Inventors:

Yunxin Y. Bo - Thousand Oaks CA, US
Shon Booker - Thousand Oaks CA, US
Marian Bryan - West Hills CA, US
Holly L. Deak - Brookline MA, US
Longbin Liu - Thousand Oaks CA, US
Kristin Andrews - Thousand Oaks CA, US
Nobuko Nishimura - West Hills CA, US
Mark H. Norman - Thousand Oaks CA, US
Kathleen Panter - Cambridge MA, US
Laurie Schenkel - Boston MA, US
Aaron C. Siegmund - Ventura CA, US
Nuria A. Tamayo - Newbury Park CA, US
Kevin Yang - San Gabriel CA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 31/47
C07D 401/02
C07D 401/14
US Classification:

514314, 546167
Abstract:

The present invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein Q, X, X, Rand Z are as defined herein.

Fused Heterocyclic Derivatives And Methods Of Use
view source
US Patent:

8524900, Sep 3, 2013
Filed:

Dec 1, 2011
Appl. No.:

13/309488
Inventors:

Brian K. Albrecht - Cambridge MA, US
David Bauer - Sudbury MA, US
Christiane M. Bode - Somerville MA, US
Shon Booker - Thousand Oaks CA, US
Alessandro Boezio - Somerville MA, US
Deborah Choquette - Medford MA, US
Derin D'Amico - Newbury Park CA, US
Jean-Christophe Harmange - Andover MA, US
Satoko Hirai - Cambridge MA, US
Richard T. Lewis - Farmingham MA, US
Longbin Liu - Thousand Oaks CA, US
Julia Lohman - Cambridge MA, US
Mark H. Norman - Thousand Oaks CA, US
Michele Potashman - Cambridge MA, US
Aaron C. Siegmund - Ventura CA, US
Stephanie K. Springer - Cambridge MA, US
Markian Stec - Moorpark CA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C07D 487/04
C07D 403/12
C07D 403/14
C07D 401/12
C07D 401/14
C07D 413/14
A61K 31/5025
A61K 31/4353
A61K 31/4523
A61P 35/00
US Classification:

544236, 514248
Abstract:

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.